2022

Mevo

For more health and less complication

  • Positioning
  • Naming
  • Verbal identity
  • Visual identity

Until then, there was no simple recipe: the doctor’s handwriting, the missing prescription paper, the saga at the pharmacies, the complicated names. From leaving the appointment to buying (or rebuying!) a medicine, a good deal of patience was needed.

With its rebranding, the healthtech company Nexodata reinvents itself to go beyond technology, seeking the best experience in a platform with integrated solutions for patients, doctors, pharmacists, and hospitals.

With an opening for a disruptive and democratic brand, which would double down in a category stagnated by the cold codes of medicine and filled with overly technical terms, Mevo arrives to evolve care, for more health and less complication. The creative path was to simplify, so that taking care of oneself becomes a light experience and part of everyday life.

From the digital medical order to the medication at home, Mevo is MEdicine that EVOlves. Mevo positions itself as a reliable platform and partner in health solutions, and at the same time brings a human perspective translated into a warm color palette, an educational tone of voice, and characters that humanize the language.

O remédio para se cuidar é uma boa dose de leveza.

A language that infuses color and vitality into a category traditionally dominated by blues and greens. This approach is rooted in the health sector but features a simple, approachable tone of voice, offering a remedy to the often complex jargon prevalent in the field. It also includes a special touch with our ‘Mevo Pills’—tablets of good humor that lend a pop and human feel to the visuals.

The language, featuring shared elements, was swiftly adopted and replicated by the team, streamlining the brand-building effort and ensuring communication consistency. The new color palette stands out so distinctly that it becomes the team’s hallmark, solidifying its role in fostering a strong culture and integration within the company.